117 related articles for article (PubMed ID: 3032617)
1. Differentiation of the drug-binding sites of calmodulin.
Zimmer M; Hofmann F
Eur J Biochem; 1987 Apr; 164(2):411-20. PubMed ID: 3032617
[TBL] [Abstract][Full Text] [Related]
2. The binding of the calcium channel blocker, bepridil, to calmodulin.
Itoh H; Tanaka T; Mitani Y; Hidaka H
Biochem Pharmacol; 1986 Jan; 35(2):217-20. PubMed ID: 3484629
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin antagonistic action of KS-504a, a novel metabolite of the fungus Mollisia ventosa.
Nakanishi S; Kuroda K; Osawa K; Kase H
Agric Biol Chem; 1990 Oct; 54(10):2697-702. PubMed ID: 1369297
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin antagonists inhibit activity of myosin light-chain kinase independent of calmodulin.
Zimmer M; Hofmann F
Eur J Biochem; 1984 Jul; 142(2):393-7. PubMed ID: 6547673
[TBL] [Abstract][Full Text] [Related]
5. Properties of caldesmon isolated from chicken gizzard.
Ngai PK; Walsh MP
Biochem J; 1985 Sep; 230(3):695-707. PubMed ID: 2998332
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
[TBL] [Abstract][Full Text] [Related]
7. Effects on calmodulin of bepridil, an antianginal agent.
Itoh H; Ishikawa T; Hidaka H
J Pharmacol Exp Ther; 1984 Sep; 230(3):737-41. PubMed ID: 6088765
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of the calmodulin antagonist bepridil on ischaemia induced in the rat myocardium.
Shikano K; Kusagawa M; Itoh H; Hidaka H
Cardiovasc Res; 1986 May; 20(5):364-8. PubMed ID: 3019548
[TBL] [Abstract][Full Text] [Related]
9. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
Agre P; Virshup D; Bennett V
J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
[TBL] [Abstract][Full Text] [Related]
10. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
Lamers JM; Cysouw KJ; Verdouw PD
Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin.
Schaeffer P; Luginer C; Follenius-Wund A; Gerard D; Stoclet JC
Biochem Pharmacol; 1987 Jun; 36(12):1989-96. PubMed ID: 3036157
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
[TBL] [Abstract][Full Text] [Related]
14. Interactions of calmodulin antagonists with calcium antagonists binding sites.
Schaeffer P; Lugnier C; Stoclet JC
Eur J Pharmacol; 1991 Apr; 206(4):325-32. PubMed ID: 1655490
[TBL] [Abstract][Full Text] [Related]
15. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
Reeves ML; Leigh BK; England PJ
Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
[TBL] [Abstract][Full Text] [Related]
16. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
Nakajima T; Katoh A
Mol Pharmacol; 1987 Jul; 32(1):140-6. PubMed ID: 3037298
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin activates bovine-cardiac myosin light-chain kinase by increasing the affinity for myosin light-chain 2.
Zimmer M; Göbel C; Hofmann F
Eur J Biochem; 1984 Mar; 139(2):295-301. PubMed ID: 6546546
[TBL] [Abstract][Full Text] [Related]
18. Properties of a monoclonal antibody directed to the calmodulin-binding domain of rabbit skeletal muscle myosin light chain kinase.
Nunnally MH; Blumenthal DK; Krebs EG; Stull JT
Biochemistry; 1987 Sep; 26(18):5885-90. PubMed ID: 2445376
[TBL] [Abstract][Full Text] [Related]
19. Interaction of calmodulin and calcium antagonists with [3H]diltiazem and [3H]nitrendipine binding sites.
Schaeffer P; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S102-3. PubMed ID: 2468847
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.
Sugden MC; Ashcroft SJ
Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
